An association exists between GH expression with lymph node metastasis, tumor stage, and the proliferative index in mammary carcinomas and with ovarian metastases in endometrial carcinomas [17]. This evidence concerns the gene GH1 and metastatic malignant neoplasm in the lymph nodes.